Dissecting Telecom's Demise, Looks at RXII, ZHNE, OPXA, SHFL, RDEN, CXM
No ratings
Opexa Therapeutics (OPXA), Shuffle Master (SHFL), Cardium Therapeutics (CXM), RXI Pharmaceuticals (RXII), Elizabeth Arden (RDEN), and Zhone Technologies (ZHNE) undergo analysis. Then, we want to revisit our bullish call on telecom from December 10th; thin